Prizvalve Pro™ Transcatheter Aortic Valve Replacement Study - Trial NCT05864456
Access comprehensive clinical trial information for NCT05864456 through Pure Global AI's free database. This phase not specified trial is sponsored by Shanghai NewMed Medical Co., Ltd. and is currently Not yet recruiting. The study focuses on Aortic Valve Stenosis. Target enrollment is 73 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Shanghai NewMed Medical Co., Ltd.
Timeline & Enrollment
N/A
Jun 29, 2023
May 01, 2028
Primary Outcome
Composite endpoint event rate at 30 days
Summary
The purpose of this clinical trial is to evaluate the safety and efficacy of the Prizvalve
 Pro™ transcatheter aortic valve system in the treatment of patients with severe aortic
 stenosis who are at high risk of surgery or who are not suitable for surgery.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05864456
Device Trial